$IVFH
INNOVATIVE FOOD HOLDINGS INC Stock $ivfh

$ivfh Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000118518523000523 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$18.83M	$17.00M	$15.64M
YoY Change	-8.23%	8.64%	28.42%
Cost Of Revenue	$14.04M	$12.91M	$11.92M
YoY Change	-12.65%	8.32%	34.22%
Gross Profit	$4.793M	$4.087M	$3.726M
YoY Change	7.73%	9.68%	12.84%
Gross Profit Margin	25.45%	24.05%	23.82%
Selling, General & Admin	$4.556M	$4.799M	$5.172M
YoY Change	-17.49%	-7.22%	6.63%
% of Gross Profit	95.06%	117.44%	138.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$97.67K	$145.4K	$138.4K
YoY Change	6.61%	5.08%	1.85%
% of Gross Profit	2.04%	3.56%	3.71%
Operating Expenses	$4.556M	$6.745M	$5.172M
YoY Change	-17.49%	30.4%	6.63%
Operating Profit	$236.8K	-$2.658M	-$1.447M
YoY Change	-122.06%	83.77%	-6.61%
Interest Expense	$209.4K	$172.4K	$211.0K
YoY Change	86.31%	-18.29%	-333.65%
% of Operating Profit	88.43%
Other Income/Expense, Net	-$207.5K	-$170.5K	$5.090K
YoY Change	37.72%	-3450.51%	-0.97%
Pretax Income	$29.31K	-$2.829M	-$1.230M
YoY Change	-102.39%	129.91%	-33.27%
Income Tax	$15.83K	$0.00	$0.00
% Of Pretax Income	54.03%
Net Earnings	$13.47K	-$2.829M	-$1.230M
YoY Change	-101.1%	129.91%	-55.76%
Net Earnings / Revenue	0.07%	-16.64%	-7.87%
Basic Earnings Per Share	$0.00	-$0.06	-$0.03
Diluted Earnings Per Share	$0.00	-$0.06	-$26.60K
COMMON SHARES
Basic Shares Outstanding	48.96M shares	48.76M shares	46.26M shares
Diluted Shares Outstanding	49.06M shares	48.46M shares	46.26M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.172M	$1.650M	$3.111M
YoY Change	161.49%	-46.96%	0.81%
Cash & Equivalents	$6.172M	$1.650M	$3.111M
Short-Term Investments
Other Short-Term Assets	$390.1K	$372.9K	$389.5K
YoY Change	14.5%	-4.28%	-24.52%
Inventory	$2.620M	$3.021M	$3.210M
Prepaid Expenses
Receivables	$4.605M	$4.830M	$3.422M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.79M	$9.874M	$10.13M
YoY Change	28.0%	-2.55%	22.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.755M	$7.828M	$8.974M
YoY Change	-4.15%	-12.77%	-4.94%
Goodwill
YoY Change
Intangibles	$10.33K	$20.66K
YoY Change	-80.0%
Long-Term Investments			$286.7K
YoY Change			0.0%
Other Assets
YoY Change
Total Long-Term Assets	$9.922M	$10.05M	$10.86M
YoY Change	-8.02%	-7.38%	-4.42%
TOTAL ASSETS
Total Short-Term Assets	$13.79M	$9.874M	$10.13M
Total Long-Term Assets	$9.922M	$10.05M	$10.86M
Total Assets	$23.71M	$19.93M	$20.99M
YoY Change	9.98%	-5.05%	6.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.232M	$4.577M	$4.214M
YoY Change	-13.0%	8.61%	32.03%
Accrued Expenses	$690.1K	$861.2K	$365.6K
YoY Change	81.29%	135.54%	-17.49%
Deferred Revenue
YoY Change
Short-Term Debt	$2.014M	$2.014M	$2.000M
YoY Change	0.0%	0.72%	0.0%
Long-Term Debt Due	$119.6K	$5.709M	$595.2K
YoY Change	-97.91%	859.25%	-71.49%
Total Short-Term Liabilities	$9.330M	$14.59M	$8.613M
YoY Change	-40.27%	69.44%	-4.76%
LONG-TERM LIABILITIES
Long-Term Debt	$8.935M	$0.00	$5.798M
YoY Change	189193.62%	-100.0%	-28.59%
Other Long-Term Liabilities	$1.013M	$1.114M	$244.7K
YoY Change	344.46%	355.09%	-12.93%
Total Long-Term Liabilities	$8.935M	$0.00	$6.043M
YoY Change	-45.13%	-100.0%	-28.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.330M	$14.59M	$8.613M
Total Long-Term Liabilities	$8.935M	$0.00	$6.043M
Total Liabilities	$19.52M	$15.99M	$14.66M
YoY Change	-38.82%	9.12%	-15.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.28M	-$37.29M
YoY Change	4.81%
Common Stock	$5.092K	$5.052K
YoY Change	1.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.141M	$1.141M
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$4.191M	$3.936M	$6.332M
YoY Change
Total Liabilities & Shareholders Equity	$23.71M	$19.93M	$20.99M
YoY Change	9.98%	-5.05%	6.89%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$13.47K	-$2.829M	-$1.230M
YoY Change	-101.1%	129.91%	-55.76%
Depreciation, Depletion And Amortization	$97.67K	$145.4K	$138.4K
YoY Change	6.61%	5.08%	1.85%
Cash From Operating Activities	$1.312M	-$3.192M	-$2.873M
YoY Change	-441.74%	11.08%	-17.84%
INVESTING ACTIVITIES
Capital Expenditures	$24.47K	$7.995K	-$4.760K
YoY Change	-127.85%	-267.96%	3.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$24.47K	-$7.995K	-$4.760K
YoY Change	-72.15%	67.96%	3.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.235M	-$49.56K	-133.5K
YoY Change	-1259.45%	-62.86%	-108.74%
NET CHANGE
Cash From Operating Activities	1.312M	-$3.192M	-2.873M
Cash From Investing Activities	-24.47K	-$7.995K	-4.760K
Cash From Financing Activities	3.235M	-$49.56K	-133.5K
Net Change In Cash	4.522M	-$3.249M	-3.012M
YoY Change	-702.42%	7.9%	52.56%
FREE CASH FLOW
Cash From Operating Activities	$1.312M	-$3.192M	-$2.873M
Capital Expenditures	$24.47K	$7.995K	-$4.760K
Free Cash Flow	$1.287M	-$3.200M	-$2.869M
YoY Change	-534.95%	11.55%	-17.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-9376
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	INNOVATIVE FOOD HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1167761
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	28411 Race Track Rd.
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bonita Springs
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34135
CY2023Q1	dei	City Area Code CityAreaCode	239
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	596-0204
CY2023Q1	dei	Security12b Title Security12bTitle	N/A
CY2023Q1	dei	Trading Symbol TradingSymbol	N/A
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48963961	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1650127	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4899398	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4829709	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4969395	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3021465	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3053852	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	372857	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	289432	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9874158	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13212077	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7827980	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7921561	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	136111	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	152425	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	536843	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	570323	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20663	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30994	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1532822	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1532822	usd
CY2023Q1	us-gaap	Assets Assets	19928577	usd
CY2022Q4	us-gaap	Assets Assets	23420202	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4796700	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6853253	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	559370	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	0	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	18198	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	18104	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1238790	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1558155	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2014333	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2014333	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5709043	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5711800	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	63877	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64987	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	193226	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	191977	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14593537	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16412609	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1041425	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72234	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87438	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	285036	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	333092	usd
CY2023Q1	us-gaap	Liabilities Liabilities	15992232	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16833139	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50569327	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49427297	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47731747	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46589717	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	5052	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4938	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42367472	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42189471	usd
CY2023Q1	ivfh	Stock Shares Vested But Not Yet Issued StockSharesVestedButNotYetIssued	832214	shares
CY2022Q4	ivfh	Stock Shares Vested But Not Yet Issued StockSharesVestedButNotYetIssued	1499940	shares
CY2023Q1	ivfh	Common Stock Value To Be Issued CommonStockValueToBeIssued	83	usd
CY2022Q4	ivfh	Common Stock Value To Be Issued CommonStockValueToBeIssued	150	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2623171	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2623171	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1141370	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1141370	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37294892	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34466126	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3936345	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6587063	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19928577	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23420202	usd
CY2023Q1	us-gaap	Revenues Revenues	16995200	usd
CY2022Q1	us-gaap	Revenues Revenues	15643111	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12908689	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11917179	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4086511	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3725932	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4799086	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5172426	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	1945650	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6744736	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5172426	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2658225	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1446494	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	294000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1900	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5090	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	172441	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	82973	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-170541	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	216117	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2828766	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1230377	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2828766	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1230377	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48462234	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46256160	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48462234	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46256160	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7410101	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	152726	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1230377	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6332450	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6587063	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	45680	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	20199000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	112169	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2828766	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3936345	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2828766	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1230377	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	145387	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	138361	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	16314	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	19691	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3088	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	178048	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	152726	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4666	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1115	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-135020	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	164124	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories And Other Operating Assets IncreaseDecreaseInInventoriesAndOtherOperatingAssets	51038	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories And Other Operating Assets IncreaseDecreaseInInventoriesAndOtherOperatingAssets	175367	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2056459	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1216020	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1600795	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-319365	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-380462	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-16314	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-19691	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3191712	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2873290	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7995	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4760	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7995	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4760	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2757	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	92816	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	46807	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	40637	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-49564	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-133453	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3249271	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3011503	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4899398	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6122671	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3205568	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650127	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3111168	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	174410	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	84961	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	ivfh	Increase In Right Of Use Assets Liabilities IncreaseInRightOfUseAssetsLiabilities	0	usd
CY2022Q1	ivfh	Increase In Right Of Use Assets Liabilities IncreaseInRightOfUseAssetsLiabilities	-13216	usd
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	usd
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	42500	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At March 31, 2023 and 2022, trade receivables from the Company’s largest customer amounted to 23% and 33%, respectively, of total trade receivables. During the three months ended March 31, 2023 and 2022, sales from the Company’s largest customer amounted to 46% and 49% of total sales, respectively.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At March 31, 2023 and December 31, 2022, the total cash in excess of these limits was $681,246 and $3,205,568, respectively.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	681246	usd
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2100000	shares
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y9M3D
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	1631406	usd
CY2022Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	700582	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1081044	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	1250944	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1558155	usd
CY2023Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	215346	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-534711	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	1238790	usd
CY2023Q1	us-gaap	Revenues Revenues	16995200	usd
CY2022	us-gaap	Revenues Revenues	15643111	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	400007	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	93600	usd
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	207839	shares
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	52919	usd
CY2023Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	192168	shares
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	45680	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	178048	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37294892	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3191712	usd
CY2023Q1	ivfh	Working Capital Deficit WorkingCapitalDeficit	4719379	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2828766	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	7695866	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3000000	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	20500000	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	4262000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4846393	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5309620	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16684	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	340225	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4829709	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4969395	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4666	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1115	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	152425	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3021465	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3053852	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3021465	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3053852	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10575238	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10567243	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2747258	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2645682	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7827980	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7921561	usd
CY2023Q1	us-gaap	Depreciation Depreciation	101576	usd
CY2022Q1	us-gaap	Depreciation Depreciation	96949	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	18790	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	23244	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	16314	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	19691	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	136111	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	136111	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	152425	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	63877	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64987	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72234	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87438	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	71116	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	68055	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7057	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	146228	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10117	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	136111	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	13216	usd
CY2023Q1	ivfh	Lease Cost Table Text Block1 LeaseCostTableTextBlock1	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1906" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-1907" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>March 31,</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td> <td id="new_id-1908" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-1909" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-1910" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>December 31,</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p> </td> <td id="new_id-1911" style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1912" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" id="new_id-1913" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(unaudited)</p> </td> <td id="new_id-1914" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1915" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1916" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1917" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1918" style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 62%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vehicles</p> </td> <td id="new_id-1919" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1920" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-1921" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">404,858</td> <td id="new_id-1922" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-1923" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1924" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-1925" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">404,858</td> <td id="new_id-1926" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warehouse Equipment</p> </td> <td id="new_id-1927" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1928" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-1929" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">555,416</td> <td id="new_id-1930" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-1931" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1932" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-1933" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">555,416</td> <td id="new_id-1934" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total before accumulated depreciation</p> </td> <td id="new_id-1935" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1936" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1937" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">960,274</td> <td id="new_id-1938" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-1939" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1940" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1941" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">960,274</td> <td id="new_id-1942" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: accumulated depreciation</p> </td> <td id="new_id-1943" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1944" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-1945" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(423,431</td> <td id="new_id-1946" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td id="new_id-1947" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1948" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-1949" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(389,951</td> <td id="new_id-1950" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td> <td id="new_id-1951" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1952" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-1953" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">536,843</td> <td id="new_id-1954" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-1955" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td id="new_id-1956" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-1957" style="width: 16%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">570,323</td> <td id="new_id-1958" style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	960274	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	960274	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	423431	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	389951	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	536843	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	570323	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	33480	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	31181	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	31181	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	478262	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	525069	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	193226	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	191977	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	285036	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	333092	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	478262	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	525069	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	193226	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	161001	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	96072	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	27963	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	478262	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6066399	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-4512914	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1553485	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2492465	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-928649	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1563816	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10331	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10231	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4576928	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	6599903	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	219772	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	253350	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4796700	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6853253	usd
CY2023Q1	ivfh	Payments Of Separation Costs PaymentsOfSeparationCosts	250000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	1945650	usd
CY2023Q1	ivfh	Payments Of Separation Costs PaymentsOfSeparationCosts	-344855	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1600795	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	559370	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	1041425	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2014333	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2014333	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5709043	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5711800	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	5709043	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	5711800	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5709043	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5711800	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5709043	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5711800	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5709043	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5709043	usd
CY2023Q1	ivfh	Common Stock Issued But Not Outstanding CommonStockIssuedButNotOutstanding	2837580	shares
CY2022Q4	ivfh	Common Stock Issued But Not Outstanding CommonStockIssuedButNotOutstanding	2837580	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	267030	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	112153	usd
CY2023Q1	ivfh	Numberof Employees NumberofEmployees	3	pure
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	15106	shares
CY2023Q1	ivfh	Number Of Directors NumberOfDirectors	2	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19428	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	178048	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50569327	shares
CY2023Q1	ivfh	Stock Shares Vested But Not Yet Issued StockSharesVestedButNotYetIssued	832214	shares
CY2023Q1	ivfh	Stock Price Target StockPriceTarget	2
CY2023Q1	ivfh	Number Of Shares Issued And Outstanding On Grant Date Multiplied By NumberOfSharesIssuedAndOutstandingOnGrantDateMultipliedBy	0.005	pure
CY2023Q1	ivfh	Maximum Number Of Shares MaximumNumberOfShares	235883	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.137	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0429	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M28D
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48114557	shares
CY2022Q1	ivfh	Stock Shares Vested But Not Yet Issued StockSharesVestedButNotYetIssued	1229289	shares
CY2023Q1	us-gaap	Share Price SharePrice	0.35
CY2022Q1	us-gaap	Share Price SharePrice	0.3
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	157849	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	25000	usd
CY2019Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	50000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000312257

Files In Submission

Name	View Source	Status
ivfh-20230331_cal.xml	Edgar Link	unprocessable
ivfh-20230331_def.xml	Edgar Link	unprocessable
0001185185-23-000523-index-headers.html	Edgar Link	pending
0001185185-23-000523-index.html	Edgar Link	pending
0001185185-23-000523.txt	Edgar Link	pending
0001185185-23-000523-xbrl.zip	Edgar Link	pending
ex_515715.htm	Edgar Link	pending
ex_515716.htm	Edgar Link	pending
ex_515717.htm	Edgar Link	pending
ex_515718.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
innovfood20230331_10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ivfh-20230331.xsd	Edgar Link	pending
ivfh_logo3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
ivfh-20230331_pre.xml	Edgar Link	unprocessable
ivfh-20230331_lab.xml	Edgar Link	unprocessable
innovfood20230331_10q_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVFH
INNOVATIVE FOOD HOLDINGS INC Stock $ivfh

2023 Q2 Form 10-Q Financial Statement

#000118518523000523 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVFH INNOVATIVE FOOD HOLDINGS INC Stock $ivfh

2023 Q2 Form 10-Q Financial Statement

#000118518523000523 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVFH
INNOVATIVE FOOD HOLDINGS INC Stock $ivfh